Insiders · Profile

Tactic Pharma LLC

10% owner at Monopar Therapeutics. Filing since 18 Dec 2019. CIK 0001727357

Company

Date

Role

Action

Amount

Of holding

24 Sep 2025

10% owner

Sold at will

550,229

$35.00M

66.9%

2 Apr 2025

10% owner

Sold at will

33,334

$1.17M

3.9%

11 Feb 2021

10% owner

Sold, plan not stated

125,000

$1.83M

42.9%

18 Dec 2019

10% owner

Bought

125,000

$1.00M

75.0%

4 decisions on file.